In a second model of esophageal cancer, activated mTOR/S6K1 was shown to phosphorylate Gli1, that consequently releases SUFU, and activates Gli1 target gene transcription, enhancing oncogenic function [102]. The gene discussed is GLI1; the disease is esophageal cancer.